2022 Volume 31 Issue 2 Pages 205-213
In this study, obesity-related genetic analysis was conducted on pharmacy staff to confirm whether genetic analysis affects prevention awareness. Subsequently, three groups were disclosed : wild-type disclosure, wild-type non-disclosure, and mutant-type disclosure. Pre- and post-disclosure questionnaire (pre- and post-questionnaire) surveys on obesity prevention were conducted and scored. The post-questionnaire score was significantly higher than the pre-questionnaire score, indicating improved awareness of obesity prevention. After categorizing the participants into low and high consciousness groups based on the pre-questionnaire scores, the pre- and post-questionnaire scores were compared among the disclosure and consciousness level groups. Additionally, we examined detailed lifestyle habits (lipid, sugar, salt, total calories, supplements, drinking, smoking, and exercise) that indicated a change in consciousness. No change in consciousness was observed between the groups. However, there was a significantly increased awareness of obesity prevention in the wild-type non-disclosure and mutant-type disclosure groups with low consciousness levels. Evaluation of low consciousness levels revealed significantly increased consciousness concerning obesity prevention in the lipid intake of the mutant-type disclosure group. The results suggest that genetic analysis for obesity prevention improves awareness in individuals with low consciousness “when their own gene polymorphism is unknown (non-disclosure)” and “when their own gene polymorphism is found to be mutated (mutant-type disclosure).” Furthermore, mutant disclosure raises awareness of improving the lipid components of diets for obesity prevention.
